Health ministry under scrutiny
The Government Inspectorate of Vietnam on September 21 announced that it will launch a special inspection of the Ministry of Health (MOH), following revelations of fraud within the ministry’s pharmaceutical licensing process.
Health ministry under scrutiny (Illustrative image. Source: VNA)Hanoi (VNA) - The Government Inspectorate of Vietnam on September 21 announced that it will launch a special inspection of the Ministry of Health (MOH), following revelations of fraud within the ministry’s pharmaceutical licensing process.
The inspection will scrutinise the MoH’s implementation of decrees relating to internal accountability mechanisms. The ministry, like other Government agencies, is required to discover and properly punish and misconduct by its officials. The recent VN Pharma controversy, in which the company was licensed to provide fraudulent drugs, could indicate inadequate oversight within the MoH.
The inspection move came after Prime Minister Nguyen Xuan Phuc gave the green light to the decision, said deputy chief of the Government Inspectorate Dang Cong Huan.
“It’s not a random inspection, it’s a planned movement,” he added.
The inspection is scheduled to last for 70 days, excluding holidays and days off, the inspectorate agency said.
The inspection team will have 13 members, led by Phan Thang Long, senior inspector and deputy head of the inspectorate agency’s Department for Socio-Cultural Inspection.
Nguyen Minh Man, acting head of the department, was assigned to supervise and submit proposals from the inspection team to Chief Inspector of the Government Inspectorate Phan Van Sau.
Huan ordered the health ministry to cooperate with the inspection team and actively provide necessary information to serve the inspection activities.
In response to the order, Deputy Ministry of Health Truong Quoc Cuong said the ministry would closely cooperate with the inspection team and provide all required information for the inspection.
In another movement, a representative of the Government Inspectorate talked with local media that next week the agency would set up another team to inspect VN Pharma’s licence to import seven drugs manufactured by Helix Pharmaceuticals Inc of Canada and the company’s registration papers for drug circulation, following the Prime Minister Nguyen Xuan Phuc’s order.
Early this month, the PM asked the agency to inspect the case and send him a report before December 31.-VNA
You should also see
PM urges stronger cooperation between Vietnamese, Chinese Ministries of Justice
Prime Minister Pham Minh Chinh has requested the Ministries of Justice of Vietnam and China to foster cooperation and mutual support, making them to be on a par with the height of the bilateral relations.
See more
Health
Free surgeries offered for cleft palate children in Thua Thien-Hue
About 80 children with cleft palate in the central province of Thua Thien-Hue and surrounding localities are to receive free check-ups and surgeries from now until April 18.
Health
Vietnam to host first int’l airway management conference
International airway experts from across the world, including the United Kingdom, United States of America, France, Italy, New Zealand, and experts from Vietnam will gather at the first South East Asian Conference of the World Alliance of Airway Management (WAAM) in Hanoi on April 13-14.
Health
Health insurance coverage necessary for all TB patients: Deputy PM
Deputy Prime Minister Tran Hong Ha on April 8 requested the Ministry of Health to work with the Vietnam Social Security and the Ministry of Labour, Invalids and Social Affairs to provide health insurance coverage for all tuberculosis (TB) patients.
Health
Blood donation – journey of love sharing
April 7 was designated as the “All People’s Voluntary Blood Donation Day” 24 years ago and, ever since, the blood donation movement has attracted the participation of tens of thousands of people across the country.
Health
Hundreds of thousands to be screened for chronic diseases through AI platforms
Hundreds of thousands of people will be screened for cardiovascular and chronic kidney diseases through AI platforms this year, and over 20,000 patients will be advised to undergo testing to assess chronic kidney disease.
